review Open AccessTop 1% cited
Vaccine Adjuvants: Putting Innate Immunity to Work
Immunity · 2010 · Vol. 33(4) · pp. 492–503
Robert L. Coffman✉(Dynavax Technologies (United States))Alan Sher(National Institute of Allergy and Infectious Diseases)Robert A. Seder(National Institute of Allergy and Infectious Diseases)
Immunotherapy and Immune ResponsesImmune Response and InflammationImmune Cell Function and InteractionInnate immune systemAcquired immune systemBiologyImmune systemImmunityImmunologyAntigenAdjuvantPattern recognition receptor
MeSH terms
Adjuvants, ImmunologicAnimalsAntigen-Presenting CellsHumansImmunity, CellularImmunity, InnateVaccinesRNA HelicasesModels, AnimalToll-Like ReceptorsImmunity, Humoral
Citations
1,888
FWCI
32.17
field-weighted impact
References
123
Percentile
100%
vs. same field & year
Citations per year
References
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Nature Immunology · 2002 · 2,484 citations
Cancer immunotherapy: moving beyond current vaccines
Nature Medicine · 2004 · 2,953 citations
Pattern Recognition Receptors and Inflammation
Cell · 2010 · 8,539 citations
Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells
European Journal of Immunology · 2001 · 772 citations
Toll-like receptor control of the adaptive immune responses
Nature Immunology · 2004 · 4,117 citations
Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens
The Journal of Experimental Medicine · 2001 · 1,932 citations
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Nature Immunology · 2010 · 8,950 citations
The Inflammasomes: Guardians of the Body
Annual Review of Immunology · 2009 · 2,393 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.